2012年度

Esaki S, Yamano K, Kiguchi J, Katsumi S, Keceli S, Okamoto H, Goshima F, Kimura H, Nishiyama Y, Murakami S. Diabetic mice show an aggravated course of herpes-simplex-virus-induced facial nerve paralysis. Otology & neurotology in press
Li Z, Yamauchi Y, Kamakura M, Murayama T, Goshima F, Kimura H, Nishiyama Y. Herpes simplex virus requires PARP activity for efficient replication and induces ERK-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1. Journal of Virology 86: 492-503 (2012)

2011年度
　　
Esaki S, Kitoh J, Katsumi S, Goshima F, Kimura H, Sawat M, Yamao K, Watanabe N, Nonoguchi N, Nakamura T, Coffin RS, Miyatake S, Nishiyama Y, Murakami S. Hepatocyte growth factor incorporated into herpes simplex virus vector accelerates facial nerve regeneration after crush injury. Gene Therapy 11:1063-1069 (2011)　　　
Gotoh K, Ito Y, Maruo S, Takada K, Mizuno T, Teranishi M, Nakata S, Nakashima T, Iwata S, Goshima F, Nakamura S, Kimura H. Replication of Epstein-Barr virus primary infection in human tonsil tissue explants. PLoS One 6: e25490 (2011).
Kamakura M, Goshima F, Luo C, Kimura H, Nishiyama Y. Herpes simplex virus induces the marked up-regulation of the zinc finger transcriptional factor INSM1, which modulates the expression and localization of the immediate early protein ICP0. Virology Journal 8:257 (2011).
Esaki S, Goshima F, Kimura H, Ikeda S, Katsumi S, Kabaya K, Watanabe N, Hashiba M, Nishiyama Y, Murakami S.:Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in mice. Acta Oto-Laryngologica,131:684-91 (2011).

2010年度

Esaki, S., Goshima, F., Katsumi, S., Watanabe, D., Ozaki, N., Murakami, S., Nishiyama, Y.Apoptosis induction after herpes simplex virus infection differs according to cell type in vivo. Archieves of Virology, 155: 1235-1245 (2010).
Fujiwara, S., Nawa, A., Luo, CH., Kamakura, M., Goshima, F., Kondo, C., Kiyono, T., Kikkawa, F., Nishiyama, Y. Carrier cell-based delivery of replication- competent HSV-1 mutants enhances antitumor effect for ovarian cancer. Cancer Gene Therapy, in press (2010).
Ushijima Y, Luo C, Kamakura M, Goshima F, Kimura H, Nishiyama Y. Herpes simplex virus UL56 interacts with and regulates the Nedd4-family ubiquitin ligase Itch. Virology Journal. 2010 Aug 3;7(1):179.
Ishida, D., Nawa, A., Tanino, T., Goshima, F., Luo, C. H., Iwaki, M., Kajiyama, H., Shibata, K., Yamamoto, E., Ino, K., Tsurumi, T., Nishiyama, Y., and Kikkawa, F. Enhanced cytotoxicity with a novel system combining the paclitaxel-2ﾕ-ethylcarbonate produrug and an HSV amplicon with attenuated replication-competent virus, HF10 as a helper virus.Cancer Letters 288: 17-27 (2010).

2009年度

Ushijima, Y., Goshima, F., Kimura, H., and Nishiyama, Y. Herpes simplex virus type 2 tegument protein UL56 relocalizes ubiquitin ligase Nedd4 and has a role in transport and/or release of virions.Virology Journal 6:168 (2009).
Ishikawa, T., Yamada, H., Oyamada, A., Goshima, F., Nishiyama, Y., and Yoshikai, Y. Protective role of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice. Journal of Virology 83: 11777-11783 (2009).


2008年度

Kagimoto, T., Yamada, H., Ishikawa, T., Maeda, N., Goshima, F., Nishiyama, Y., Furue, M., Yoshikai, Y. A regulatory role of interleukin 15 in wound healing and mucosal in1. Journal of Leukocyte Biology, 83: 165-172 (2008).
Watanabe, D., Goshima, F., Mori, I., Tanada, Y., Matsumoto, Y., Nishiyama, Y. Oncolytic viral therapy for malignant melanoma with herpes simplex virus type 1 mutant HF10. Journal of Dermatological Science 50: 185-196 (2008).
Kamakura, M., Nawa, A., Ushijima, Y., Goshima, F., Kawaguchi, Y., Kikkawa, F., Nishiyama, Y. Microarray analysis of transcriptional responses to infection by herpes simplex virus types 1 and 2 and their US3-deficient mutants Microbes and Infection 10: 405-413 (2008).
Ushijima Y, Koshizuka T, Goshima F, Kimura H, Nishiyama Y.
Herpes Simplex Virus Type 2 UL56 Interacts with the Ubiquitin Ligase Nedd4 and Increases its Ubiquitination. Journal of Virology 82: 5220-5233 (2008).
Nawa A, Luo C, Zhang L, Ushjima Y, Ishida D, Kamakura M, Fujimoto Y, Goshima F, Kikkawa F, Nishiyama Y. Non-engineered, naturally oncolytic herpes simplex virus HSV1 HF-10: applications for cancer gene therapy. Curr Gene Ther 8: 208-221 (2008).

2007年度

Ushijima Y, Luo C, Goshima F, Yamauchi Y, Kimura H, Nishiyama Y.Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus.Microbes and Infection 9: 142-149 (2007).
Luo, C., Nawa, A., Yamauchi, Y., Kohno, S., Ushijima, Y., Goshima, F. and Nishiyama, Y.Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide. Virus Genes 34: 263-272 (2007).
Kohno, S., Luo, C., Nawa, A., Fujimoto, Y., Waranabe, D., Goshima, F., Tsurumi, T. and Nishiyama, Y. Oncolytic Virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type I mutant HF10 as a helperCancer Gene Therapy, 14: 918-926 (2007).
Shimoyama, S., Goshima, F., Teshigahara, O., Kasuya, H., Kodera, Y., Nakao, A. and Nishiyama, Y. Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination models. Hepato-Gastroenterology, 54: 1038-1042 (2007).
Kasuya, H.,Nishiyama, Y., Nomoto, S., Goshima, F., Takeda, S., Watanabe, I., Nomura, N., Shikano, T., Fujii, T., Kanazumi, N. and Nakao, A. Suitability of a US3-inactivated HSV mutant(L1BR1) as an oncolytic-virus for pancreatic cancer therpay. Cancer Gene Therapy 14: 533-542 (2007).
Nakao, A., Takeda, S., Shimoyama, S., Kasuya, H., Kimata, H., Teshigahara, O., Sawaki, M., Kikumori, T., Kodera, Y., Nagasaka, T., Goshima, F., Nishiyama, Y. and Imai, T. Clinical experiment of mutant herpes simplex virus HF10 therapy for cancer. Curr Cancer Drug Targets 7: 169-174 (2007).
Luo, C., Mori, I., Goshima, F., Ushijima, Y., Nawa, A., Kimura, H., Nishiyama, Y.
Replication-competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment.Journal of Gene Medicine, 9: 875-883(2007).

2006年度

Koshizuka, T., Kawaguchi, Y., Goshima, F., Mori, I. and Nishiyama, Y.　Association of two membrane proteins encoded by herpes simplex virus type2, UL11 and UL56. Virus Genes 32, 157-167 (2006).
Kimata, H., Imai, T., Kikumori, T., Teshigawara, O., Nagasaka, T., Goshima, F., Nishiyama, Y and Nakao, A.Pilot study of oncolytic viral therapy using mutant herpes simplex virus HF10 against recurrent metastatic breast cancer.Annals of Surgical Oncology 13: 1078-1084 (2006).
Fujimoto, Y., Mizuno, T., Sugiura, S., Goshima, F., Kohno, S., Nakashima, T. and Nishiyama, Y.Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinoma.Acta Oto-Laryngologia 126: 1115-1117 (2006).
Mori, I., Goshima, F., Watanabe, D., Ito, H., Koide, N., Yoshida, T., Liu, B., Kimura, Y., Yokochi, T. and Nishiyama, Y.Herpes simplex virus US3 protein kinase regulates virus-induced apoptosis in olfactory and vomeronasal chemosensory neurons in vivo.Microbes and infection 8:1806-1812 (2006).

2005年度

Kohno, S., Luo, C., Goshima, F., Nishiyama, Y., Sata, T. and Ono, Y.　Herpes simplex virus type 1 mutant HF10 oncolytic virutherapy for bladder cancer.　Urology 66: 1116-1121 (2005).
Mori I, Goshima F, Mizuno T, Imai Y, Kohsaka S, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y.　Axonal injury in experimental herpes simplex encephalitis. Brain Res. 2005 Sep 28;1057(1-2):186-90.
Mori I, Liu B, Goshima F, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y.　
HF10, an attenuated herpes simplex virus (HSV) type 1 clone, lacks neuroinvasiveness and protects mice against lethal challenge with HSV types 1 and 2. Microbes Infect. 2005 Jul 26; [Epub ahead of print]
Matsuzaki A, Yamauchi Y, Kato A, Goshima F, Kawaguchi Y, Yoshikawa T, Nishiyama Y.　
US3 protein kinase of herpes simplex virus type 2 is required for the stability of the UL46-encoded tegument protein and its association with virus particles. J Gen Virol. 2005 Jul;86(Pt 7):1979-85.
Mori I, Koshizuka T, Goshima F, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y.　
Intercellular trafficking activity of herpes simplex virus US11 gene product in the mouse brain. Brain Res Mol Brain Res. 2005 May 20;136(1-2):158-63.
Mori I, Goshima F, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y. The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus. Virology. 2005 Mar 30;334(1):51-8.
Nishimura N, Yoshikawa T, Ozaki T, Sun H, Goshima F, Nishiyama Y, Asano Y, Kurata T, Iwasaki T.　In vitro and in vivo analysis of human herpesvirus-6 U90 protein expression. J Med Virol. 2005 Jan;75(1):86-92.

2004年度

Nakao A, Kimata H, Imai T, Kikumori T, Teshigahara O, Nagasaka T, Goshima F, Nishiyama Y. Intratumoral injection of herpes simplex virus HF10 in recurrent breast cancer. Ann Oncol. 2004 Jun;15(6):988-9. No abstract available.
Sugiura S, Goshima F, Takakuwa H, Sata T, Nakashima T, Nishiyama Y. Treatment of solid sarcomas in immunocompetent mice with novel, oncolytic herpes simplex viruses. Otolaryngol Head Neck Surg. 2004 Apr;130(4):470-8.
Nishimura H, Yajima T, Kagimoto Y, Ohata M, Watase T, Kishihara K, Goshima F, Nishiyama Y, Yoshikai Y. Intraepithelial gammadelta T cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type 2. J Virol. 2004 May;78(9):4927-30.
Teshigahara O, Goshima F, Takao K, Kohno S, Kimata H, Nakao A, Nishiyama Y. Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10. J Surg Oncol. 2004 Jan;85(1):42-7.

2003年度

Mori I, Goshima F, Koshizuka T, Imai Y, Kohsaka S, Koide N, Sugiyama T, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y.　 Iba1-expressing microglia respond to herpes simplex virus infection in the mouse trigeminal ganglion. Brain Res Mol Brain Res. 2003 Dec 12;120(1):52-6.
Mori I, Goshima F, Koshizuka T, Koide N, Sugiyama T, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y.　 The US3 protein kinase of herpes simplex virus attenuates the activation of the c-Jun N-terminal protein kinase signal transduction pathway in infected piriform cortex neurons of C57BL/6 mice. Neurosci Lett. 2003 Nov 20;351(3):201-5.
Yamauchi Y, Daikoku T, Goshima F, Nishiyama Y. Herpes simplex virus UL14 protein blocks apoptosis. Microbiol Immunol. 2003;47(9):685-9.
Nawa A, Nozawa N, Goshima F, Nagasaka T, Kikkawa F, Niwa Y, Nakanishi T, Kuzuya K, Nishiyama Y. Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model. Gynecol Oncol. 2003 Oct;91(1):81-8.
Mori I, Goshima F, Koshizuka T, Koide N, Sugiyama T, Yoshida T, Yokochi T, Nishiyama Y, Kimura Y.Differential activation of the c-Jun N-terminal kinase/stress-activated protein kinase and p38 mitogen-activated protein kinase signal transduction pathways in the mouse brain upon infection with neurovirulent influenza A virus. J Gen Virol. 2003 Sep;84(Pt 9):2401-8.
Yoshikawa T, Goshima F, Akimoto S, Ozaki T, Iwasaki T, Kurata T, Asano Y, Nishiyama Y.
Human herpesvirus 6 infection of human epidermal cell line: pathogenesis of skin manifestations. J Med Virol. 2003 Sep;71(1):62-8.
Kimata H, Takakuwa H, Goshima F, Teshigahara O, Nakao A, Kurata T, Sata T, Nishiyama Y.
Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex viruses. Hepatogastroenterology. 2003 Jul-Aug;50(52):961-6.
Takakuwa H, Goshima F, Nozawa N, Yoshikawa T, Kimata H, Nakao A, Nawa A, Kurata T, Sata T, Nishiyama Y. Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice. Arch Virol. 2003 Apr;148(4):813-25.

2002年度

Murata T, Goshima F, Nishizawa Y, Daikoku T, Takakuwa H, Ohtsuka K, Yoshikawa T, Nishiyama Y.　 Phosphorylation of cytokeratin 17 by herpes simplex virus type 2 US3 protein kinase. Microbiol Immunol. 2002;46(10):707-19.
Yamauchi Y, Goshima F, Yoshikawa T, Nozawa N, Koshizuka T, Nishiyama Y.　Intercellular trafficking of herpes simplex virus type 2 UL14 deletion mutant proteins. Biochem Biophys Res Commun. 2002 Nov 1;298(3):357-63.
Murata T, Goshima F, Takakuwa H, Nishiyama Y.　Excretion of herpes simplex virus type 2 glycoprotein D into the culture medium. J Gen Virol. 2002 Nov;83(Pt 11):2791-5.
Mori I, Goshima F, Imai Y, Kohsaka S, Sugiyama T, Yoshida T, Yokochi T, Nishiyama Y, Kimura Y. Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosis. J Gen Virol. 2002 Sep;83(Pt 9):2109-16.
Nozawa N, Daikoku T, Yamauchi Y, Takakuwa H, Goshima F, Yoshikawa T, Nishiyama Y.
Identification and characterization of the UL7 gene product of herpes simplex virus type 2. Virus Genes. 2002 Jun;24(3):257-66.
Murata T, Goshima F, Yamauchi Y, Koshizuka T, Takakuwa H, Nishiyama Y.　 Herpes simplex virus type 2 US3 blocks apoptosis induced by sorbitol treatment. Microbes Infect. 2002 Jun;4(7):707-12.
Koshizuka T, Goshima F, Takakuwa H, Nozawa N, Daikoku T, Koiwai O, Nishiyama Y. Identification and characterization of the UL56 gene product of herpes simplex virus type 2. J Virol. 2002 Jul;76(13):6718-28.
Yamauchi Y, Wada K, Goshima F, Daikoku T, Ohtsuka K, Nishiyama Y. Herpes simplex virus type 2 UL14 gene product has heat shock protein (HSP)-like functions.　J Cell Sci. 2002 Jun 15;115(Pt 12):2517-27.
Yoshikawa T, Asano Y, Akimoto S, Ozaki T, Iwasaki T, Kurata T, Goshima F, Nishiyama Y. Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis. J Med Virol. 2002 Apr;66(4):497-505.

2001年度

Goshima F, Watanabe D, Suzuki H, Takakuwa H, Yamada H, Nishiyama Y. The US2 gene product of herpes simplex virus type 2 interacts with cytokeratin 18. Arch Virol. 2001;146(11):2201-9.
Takakuwa H, Goshima F, Koshizuka T, Murata T, Daikoku T, Nishiyama Y.　Related Herpes simplex virus encodes a virion-associated protein which promotes long cellular processes in over-expressing cells. Genes Cells. 2001 Nov;6(11):955-66.
Koshizuka T, Takakuwa H, Goshima F, Murata T, Nishiyama Y.
The US11 gene product of herpes simplex virus has intercellular trafficking activity. Biochem Biophys Res Commun. 2001 Nov 2;288(3):597-602.
Hong-Yan Z, Murata T, Goshima F, Takakuwa H, Koshizuka T, Yamauchi Y, Nishiyama Y.　
Identification and characterization of the UL24 gene product of herpes simplex virus type 2. Virus Genes. 2001 Jun;22(3):321-7.
Yamauchi Y, Shiba C, Goshima F, Nawa A, Murata T, Nishiyama Y. Herpes simplex virus type 2 UL34 protein requires UL31 protein for its relocation to the internal nuclear membrane in transfected cells. J Gen Virol. 2001 Jun;82(Pt 6):1423-8.
Murata T, Goshima F, Daikoku T, Takakuwa H, Nishiyama Y.Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation. Genes Cells. 2000 Dec;5(12):1017-27.
Yamauchi Y, Wada K, Goshima F, Takakuwa H, Daikoku T, Yamada M, Nishiyama Y.The UL14 protein of herpes simplex virus type 2 translocates the minor capsid protein VP26 and the DNA cleavage and packaging UL33 protein into the nucleus of coexpressing cells. J Gen Virol. 2001 Feb;82(Pt 2):321-30.
Goshima F, Watanabe D, Takakuwa H, Wada K, Daikoku T, Yamada M, Nishiyama Y.Herpes simplex virus UL17 protein is associated with B capsids and colocalizes with ICP35 and VP5 in infected cells. Arch Virol. 2000;145(2):417-26.
Murata T, Goshima F, Koshizuka T, Takakuwa H, Nishiyama Y.A single amino acid substitution in the ICP27 protein of herpes simplex virus type 1 is responsible for its resistance to leptomycin B.
J Virol. 2001 Jan;75(2):1039-43.

2000年度

Kato K, Daikoku T, Goshima F, Kume H, Yamaki K, Nishiyama Y.
Synthesis, subcellular localization and VP16 interaction of the herpes simplex virus type 2 UL46 gene product. Arch Virol. 2000;145(10):2149-62.
Inagaki-Ohara K, Daikoku T, Goshima F, Nishiyama Y. Impaired induction of protective immunity by highly virulent herpes simplex virus type 2 in a murine model of genital herpes.　Arch Virol. 2000;145(10):1989-2002.
Asano S, Honda T, Goshima F, Nishiyama Y, Sugiura Y. US3 protein kinase of herpes simplex virus protects primary afferent neurons from virus-induced apoptosis in ICR mice. Neurosci Lett. 2000 Nov 17;294(2):105-8.
Tsunobuchi H, Nishimura H, Goshima F, Daikoku T, Nishiyama Y, Yoshikai Y. Memory-type CD8+ T cells protect IL-2 receptor alpha-deficient mice from systemic infection with herpes simplex virus type 2. J Immunol. 2000 Oct 15;165(8):4552-60.
Watanabe D, Ushijima Y, Goshima F, Takakuwa H, Tomita Y, Nishiyama Y.
Identification of nuclear export signal in UL37 protein of herpes simplex virus type 2. Biochem Biophys Res Commun. 2000 Oct 5;276(3):1248-54.
Tsunobuchi H, Nishimura H, Goshima F, Daikoku T, Suzuki H, Nakashima I, Nishiyama Y, Yoshikai Y. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus. Virology. 2000 Sep 15;275(1):57-66.
Shiba C, Daikoku T, Goshima F, Takakuwa H, Yamauchi Y, Koiwai O, Nishiyama Y.　 The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein that is significant for virus envelopment. J Gen Virol. 2000 Oct;81(Pt 10):2397-405.
Murata T, Goshima F, Daikoku T, Inagaki-Ohara K, Takakuwa H, Kato K, Nishiyama Y.
Mitochondrial distribution and function in herpes simplex virus-infected cells. J Gen Virol. 2000 Feb;81(Pt 2):401-6.

1999年度

Hata S, Koyama AH, Shiota H, Adachi A, Goshima F, Nishiyama Y. Antiapoptotic activity of herpes simplex virus type 2: the role of US3 protein kinase gene. Microbes Infect. 1999 Jul;1(8):601-7.
Wada K, Goshima F, Takakuwa H, Yamada H, Daikoku T, Nishiyama Y. Identification and characterization of the UL14 gene product of herpes simplex virus type 2. J Gen Virol. 1999 Sep;80 ( Pt 9):2423-31.
Asano S, Honda T, Goshima F, Watanabe D, Miyake Y, Sugiura Y, Nishiyama Y.　 US3 protein kinase of herpes simplex virus type 2 plays a role in protecting corneal epithelial cells from apoptosis in infected mice. J Gen Virol. 1999 Jan;80 ( Pt 1):51-6.

1998年度

Koyama AH, Akari H, Adachi A, Goshima F, Nishiyama Y.　Induction of apoptosis in HEp-2 cells by infection with herpes simplex virus type 2. Arch Virol. 1998;143(12):2435-41.
Daikoku T, Ikenoya K, Yamada H, Goshima F, Nishiyama Y.　Identification and characterization of the herpes simplex virus type 1 UL51 gene product.　J Gen Virol. 1998 Dec;79 ( Pt 12):3027-31.
Jiang YM, Yamada H, Goshima F, Daikoku T, Oshima S, Wada K, Nishiyama Y.
Characterization of the herpes simplex virus type 2 (HSV-2) US2 gene product and a US2-deficient HSV-2 mutant.　J Gen Virol. 1998 Nov;79 ( Pt 11):2777-84.
Yamada H, Jiang YM, Oshima S, Wada K, Goshima F, Daikoku T, Nishiyama Y.　Characterization of the UL4 gene product of herpes simplex virus type 2. Arch Virol. 1998;143(6):1199-207.
Oshima S, Daikoku T, Shibata S, Yamada H, Goshima F, Nishiyama Y. Characterization of the UL16 gene product of herpes simplex virus type 2. Arch Virol. 1998;143(5):863-80.
Goshima F, Daikoku T, Yamada H, Oshima S, Tsurumi T, Nishiyama Y. Subcellular localization of the US3 protein kinase of herpes simplex virus type 2. Arch Virol. 1998;143(3):613-22.

1997年度以前

Daikoku T, Shibata S, Goshima F, Oshima S, Tsurumi T, Yamada H, Yamashita Y, Nishiyama Y.　
Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2. Virology. 1997 Aug 18;235(1):82-93.
Yamamoto-Goshima F, Maeno K, Morishita T, Ueda M, Fujita Y, Nakajima K, Yoshii S.
Role of neuraminidase in the morphogenesis of influenza B virus. J Virol. 1994 Feb;68(2):1250-4.
Yamamoto-Goshima F, Maeno K. Approach to the involvement of influenza B neuraminidase in the cleavage of HA by host cell protease using low pH-induced cell fusion reaction. Microbiol Immunol. 1994;38(10):819-22.
Yamamoto-Goshima F, Aoki H, Takada T, Toda S, Yoshii S, Maeno K. Isolation and classification of temperature-sensitive mutants of influenza B virus. Microbiol Immunol. 1994;38(9):757-61.
Shibata S, Yamamoto-Goshima F, Maeno K, Hanaichi T, Fujita Y, Nakajima K, Imai M, Komatsu T, Sugiura S. Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase. J Virol. 1993 Jun;67(6):3264-73.
Yamada Y, Shimokata K, Yamada Y, Yamamoto N, Goshima F, Nishiyama Y. Inhibition of influenza A virus replication by a kanamycin derivative. Antiviral Res. 1991 Mar-Apr;15(3):171-82.
Goshima FY, Maeno K. Persistent infection of MDCK cells by influenza C virus: initiation and characterization. J Gen Virol. 1989 Dec;70 ( Pt 12):3481-5.
Yamamoto-Goshima F, Maeno K, Shibata S, Mano H, Suzuki T, Nishi Y. Analysis of the mechanism of influenza B virus inactivation by guinea pig serum. Arch Virol. 1988;103(3-4):275-82.
Yamamoto F, Maeno K, Shibata S, Iinuma M, Miyama A, Kawamoto Y. Inactivation of influenza B virus by normal guinea-pig serum. J Gen Virol. 1987 Apr;68 ( Pt 4):1135-41.
Yamamoto F, Fujioka H, Iinuma M, Takano M, Maeno K, Nagai Y, Ito Y. Enhancement of Newcastle disease virus-induced fusion of mouse L cells by sodium vanadate. Microbiol Immunol. 1984;28(1):75-83.
Ito Y, Yamamoto F, Takano M, Maeno K, Shimokata K, Iinuma M, Hara K, Iijima S. Detection of cellular receptors for Sendai virus in mouse tissue sections. Arch Virol. 1983;75(1-2):103-13.
Ito Y, Yamamoto F, Takano M, Maeno K, Shimokata K, Iinuma M, Hara K, Iijima S.
Comparative studies on the distribution mode of orthomyxo-virus and paramyxo-virus receptor possessing cells in mice and birds. Med Microbiol Immunol (Berl). 1982;171(1):59-68.